News & Analysis
- Data & Tools
- IAM Market
- Login | Register
Anita Nador is a partner in Gowling WLG's Toronto office and a member of the firm's national Life Sciences Group. She is a lawyer and registered patent agent in Canada and the United States, and a registered trademark agent in Canada.
Recognized as a leader in her field by the world's top legal and IP rankings organizations, including IAM Strategy 300: The World's Leading IP Strategists, Anita focuses her practice on intellectual property (IP), regulatory and commercialization planning, primarily in the life sciences and chemical sectors - including pharmaceuticals, biologics, natural health products, agriculture, foods and medical devices.
Anita is particularly distinguished for her ability to pair sophisticated IP experience with a nuanced understanding of corporate transactional regulatory law - ensuring her clients' commercial interests and IP strategies are strongly aligned. Her practice encompasses all aspects of these areas, including:
Anita also assists clients with related agreements, such as asset purchase, license, development, clinical trial, consulting, and master services agreements and has advised and conducted due diligence on many commercial transactions and financings.
A former researcher at Brigham and Women's Hospital/Harvard Medical School in Boston and Allelix Biopharmaceuticals in Mississauga, Anita grounds her advice in first-hand knowledge of the day-to-day commercial and scientific realities that shape her clients' businesses.
Anita services a range of clients - from startups and academic institutions to some of the world's largest pharmaceutical companies. In recognition of her ability to add real value to these and other clients' businesses, Anita was a recipient of a 2016 Client Choice Award, which described her as a "trustworthy and extremely knowledgeable adviser" and praised her legal advice as "outstanding."
Anita regularly speaks, teaches and writes on topics related to intellectual property, regulatory compliance and technology transfer issues. She is currently an adjunct professor at the University of Toronto's Institute of Health Policy, Management and Evaluation.
Unlock unlimited access to all IAM content